June 30, 2015 Nutra Pharma has announced that they have engaged Pickwick Capital Partners to act as the Company's investment banking partner. June 30, 2015 -- Coral Springs, Florida -- Nutra Pharma Corporation (OTC: NPHC), a biotechnology company marketing Nyloxin® and Pet Pain-Away in the over-the-counter (OTC) pain management market, and which is also developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV), Adrenomyeloneuropathy (AMN) and Pain,

June 23, 2015 Nutra Pharma has announced that they have completed upgrades and an expansion to the reptile farm that houses the Asian cobras utilized in the production of the Company's OTC pain drug, Nyloxin® June 23, 2015 -- Coral Springs, Florida -- Nutra Pharma Corporation (OTC: NPHC), a biotechnology company marketing Nyloxin® and Pet Pain-Away in the over-the-counter (OTC) pain management market, and which is also developing treatments for Multiple Sclerosis (MS), Human

June 09, 2015 Nutra Pharma has announced that they have entered into a strategic collaboration with Nationwide Laboratory Services, Inc. in which Nationwide occupies a portion of Nutra Pharma's production facility in Plantation Florida, sharing their regulatory personnel and capacities with Nutra Pharma. June 9, 2015 -- Coral Springs, Florida -- Nutra Pharma Corporation (OTC: NPHC), a biotechnology company marketing Nyloxin and Pet Pain-Away in the over-the-counter (OTC) pain